Yanling Zhou

2.4k total citations
136 papers, 1.7k citations indexed

About

Yanling Zhou is a scholar working on Pharmacology, Biological Psychiatry and Experimental and Cognitive Psychology. According to data from OpenAlex, Yanling Zhou has authored 136 papers receiving a total of 1.7k indexed citations (citations by other indexed papers that have themselves been cited), including 61 papers in Pharmacology, 54 papers in Biological Psychiatry and 46 papers in Experimental and Cognitive Psychology. Recurrent topics in Yanling Zhou's work include Treatment of Major Depression (61 papers), Tryptophan and brain disorders (54 papers) and Mental Health Research Topics (40 papers). Yanling Zhou is often cited by papers focused on Treatment of Major Depression (61 papers), Tryptophan and brain disorders (54 papers) and Mental Health Research Topics (40 papers). Yanling Zhou collaborates with scholars based in China, United States and Canada. Yanling Zhou's co-authors include Yuping Ning, Wei Zheng, Yanni Zhan, Xiaofeng Lan, Chengyu Wang, Lijian Chen, Weijian Liu, Hanqiu Li, Hongbo He and Weijian Liu and has published in prestigious journals such as Journal of Clinical Investigation, SHILAP Revista de lepidopterología and PLoS ONE.

In The Last Decade

Yanling Zhou

126 papers receiving 1.7k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Yanling Zhou China 24 845 790 468 358 355 136 1.7k
Alexander Kautzky Austria 27 635 0.8× 384 0.5× 457 1.0× 365 1.0× 336 0.9× 83 1.8k
Sarah Pillemer United States 10 1.3k 1.5× 1.0k 1.3× 469 1.0× 280 0.8× 339 1.0× 13 1.9k
Rayan K. Al Jurdi United States 15 1.1k 1.4× 962 1.2× 622 1.3× 260 0.7× 281 0.8× 21 1.9k
Lawrence T. Park United States 20 894 1.1× 890 1.1× 260 0.6× 227 0.6× 342 1.0× 35 1.9k
Lucie Bartova Austria 23 692 0.8× 453 0.6× 415 0.9× 462 1.3× 301 0.8× 72 1.4k
Markus Dold Austria 24 823 1.0× 498 0.6× 970 2.1× 571 1.6× 256 0.7× 67 2.2k
Chen-Jee Hong Taiwan 22 580 0.7× 492 0.6× 384 0.8× 240 0.7× 510 1.4× 49 1.7k
Kimberly Cooper United States 14 1.2k 1.5× 869 1.1× 466 1.0× 345 1.0× 269 0.8× 25 1.9k
André Tadić Germany 24 646 0.8× 417 0.5× 416 0.9× 383 1.1× 474 1.3× 43 1.9k
Laili Soleimani United States 16 798 0.9× 690 0.9× 308 0.7× 203 0.6× 175 0.5× 35 1.3k

Countries citing papers authored by Yanling Zhou

Since Specialization
Citations

This map shows the geographic impact of Yanling Zhou's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yanling Zhou with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yanling Zhou more than expected).

Fields of papers citing papers by Yanling Zhou

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yanling Zhou. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yanling Zhou. The network helps show where Yanling Zhou may publish in the future.

Co-authorship network of co-authors of Yanling Zhou

This figure shows the co-authorship network connecting the top 25 collaborators of Yanling Zhou. A scholar is included among the top collaborators of Yanling Zhou based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yanling Zhou. Yanling Zhou is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Li, Weicheng, Xiaofeng Lan, Fan Zhang, et al.. (2025). White matter free water and depressive symptoms in medication-free depressed adolescents: moderation by peripheral inflammation. Translational Psychiatry. 15(1). 407–407.
3.
4.
5.
Zheng, Wei, Yanling Zhou, Xiaofeng Lan, et al.. (2024). Comparison of the Antianhedonic Effects of Repeated-dose Intravenous Ketamine in Older and Younger Adults with Major Depressive Episode. Current Neuropharmacology. 23(2). 232–239. 1 indexed citations
6.
7.
Lan, Xiaofeng, Chengyu Wang, Fan Zhang, et al.. (2023). Pain mediates the improvement of social functions of repeated intravenous ketamine in patients with unipolar and bipolar depression. Journal of Affective Disorders. 334. 152–158. 1 indexed citations
8.
Zheng, Wei, Yanling Zhou, Chengyu Wang, Xiaofeng Lan, & Yuping Ning. (2023). A comparative analysis of antidepressant and anti-suicidal effects of repeated ketamine infusions in elderly and younger adults with depression. Journal of Affective Disorders. 334. 145–151. 4 indexed citations
9.
Zhang, Bin, et al.. (2023). Pre-treatment functional connectivity of the cingulate cortex predicts anti-suicidal effects of serial ketamine infusions. European Psychiatry. 66(1). e31–e31. 1 indexed citations
10.
Zhou, Yanling, Xiaofeng Lan, Fan Zhang, et al.. (2023). Effect of Repeated Intravenous Esketamine on Adolescents With Major Depressive Disorder and Suicidal Ideation: A Randomized Active-Placebo-Controlled Trial. Journal of the American Academy of Child & Adolescent Psychiatry. 63(5). 507–518. 25 indexed citations
11.
Zheng, Wei, Yanling Zhou, Chengyu Wang, et al.. (2022). Baseline Plasma BDNF Levelsare Associated with Antianhedonic Effects ofRepeated-Dose Intravenous Ketamine in Major Depressive Disorder. Current Neuropharmacology. 21(4). 1013–1021. 9 indexed citations
12.
Paudel, Deepak, et al.. (2020). Virtual Reality Exposure Therapy (VRET) for Anxiety Due to Fear of COVID-19 Infection: A Case Series. SHILAP Revista de lepidopterología. 1 indexed citations
13.
Lan, Xiaofeng, Yanling Zhou, Wei Zheng, et al.. (2020). Association between cognition and suicidal ideation in patients with major depressive disorder: A longitudinal study. Journal of Affective Disorders. 272. 146–151. 23 indexed citations
14.
Zhan, Yanni, Bin Zhang, Yanling Zhou, et al.. (2019). A preliminary study of anti-suicidal efficacy of repeated ketamine infusions in depression with suicidal ideation. Journal of Affective Disorders. 251. 205–212. 43 indexed citations
15.
Zhou, Yanling, Wei Zheng, Weijian Liu, et al.. (2018). Cross-sectional relationship between kynurenine pathway metabolites and cognitive function in major depressive disorder. Psychoneuroendocrinology. 101. 72–79. 45 indexed citations
16.
Liu, Weijian, Yanling Zhou, Wei Zheng, et al.. (2018). Mediating effect of neurocognition between severity of symptoms and social-occupational function in anxious depression. Journal of Affective Disorders. 246. 667–673. 9 indexed citations
17.
Zheng, Wei, Yanling Zhou, Weijian Liu, et al.. (2018). Rapid and longer-term antidepressant effects of repeated-dose intravenous ketamine for patients with unipolar and bipolar depression. Journal of Psychiatric Research. 106. 61–68. 134 indexed citations
18.
Wu, Fengchun, Yuanyuan Huang, Yanling Zhou, et al.. (2017). Factors influencing relapse in schizophrenia: A longitudinal study in China. Biomedical Research-tokyo. 28(9). 4076–4082. 5 indexed citations
19.
Huang, Xingbing, Yanling Zhou, Hongbo He, et al.. (2017). Association of serum BDNF levels with psychotic symptom in chronic patients with treatment-resistant depression in a Chinese Han population. Psychiatry Research. 257. 279–283. 9 indexed citations
20.
Zhou, Yanling, Robert A. Rosenheck, & Hongbo He. (2014). Health insurance in China: variation in co-payments and psychiatric hospital utilization.. PubMed. 17(1). 25–32. 12 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Alexander Kautzky Breakdown of academic impact, for papers by Sarah Pillemer Breakdown of academic impact, for papers by Rayan K. Al Jurdi Breakdown of academic impact, for papers by Lawrence T. Park Breakdown of academic impact, for papers by Lucie Bartova Breakdown of academic impact, for papers by Markus Dold Breakdown of academic impact, for papers by Chen-Jee Hong Breakdown of academic impact, for papers by Kimberly Cooper Breakdown of academic impact, for papers by André Tadić Breakdown of academic impact, for papers by Laili Soleimani
Rankless by CCL
2026